Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALDX

Aldeyra Therapeutics Inc

May 14 • 04:00PM ET

1.66

-0.04 -2.35 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: EYPT OCGN TRVI VNDA SGMO

| Held by: VTI IWM VXF IWO VTWO VHT IWC DFMC PRFZ ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.46	Insider Own	7.44%	Shs Outstand	60.32M	Perf Week	-4.05%
Market Cap	100.14M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	1.70%	Shs Float	55.85M	Perf Month	-9.29%
Enterprise Value	50.65M	PEG	-	EPS next Q	-0.07	Inst Own	64.27%	Short Float	13.19%	Perf Quarter	-68.38%
Income	-27.37M	P/S	-	EPS this Y	25.45%	Inst Trans	5.45%	Short Ratio	2.36	Perf Half Y	-68.26%
Sales	0.00M	P/B	2.38	EPS next Y	44.11%	ROA	-34.28%	Short Interest	7.36M	Perf YTD	-67.95%
Book/sh	0.70	P/C	1.54	EPS next 5Y	-	ROE	-51.76%	52W High	6.18 -73.12%	Perf Year	-23.50%
Cash/sh	1.08	P/FCF	-	EPS past 3/5Y	19.04% 12.61%	ROIC	-64.92%	52W Low	1.07 55.14%	Perf 3Y	-83.66%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.34% 5.98%	Perf 5Y	-86.33%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	53.00%	Oper. Margin	-	ATR (14)	0.13	Perf 10Y	-69.87%
Dividend Ex-Date	-	Quick Ratio	2.69	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.53	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.69	EPS Q/Q	65.50%	SMA20	-0.12%	Beta	1.16	Target Price	7.00
Payout	-	Debt/Eq	0.37	Sales Q/Q	-	SMA50	-23.65%	Rel Volume	0.23	Prev Close	1.70
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 12	SMA200	-62.44%	Avg Volume	3.12M	Price	1.66
IPO	May 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.43% -	Trades		Volume	706,500	Change	-2.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)